Ad is loading...
JGSVX
Price
$23.24
Change
+$0.43 (+1.89%)
Updated
Nov 21 closing price
VSGAX
Price
$102.83
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

JGSVX vs VSGAX

Header iconJGSVX vs VSGAX Comparison
Open Charts JGSVX vs VSGAXBanner chart's image
JPMorgan Small Cap Growth R5
Price$23.24
Change+$0.43 (+1.89%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Growth Index Admiral
Price$102.83
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
JGSVX vs VSGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JGSVX vs. VSGAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGSVX is a Buy and VSGAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSGAX has more cash in the bank: 35.8B vs. JGSVX (3.75B). VSGAX pays higher dividends than JGSVX: VSGAX (0.66) vs JGSVX (0.00). JGSVX was incepted earlier than VSGAX: JGSVX (8 years) vs VSGAX (13 years). JGSVX is a more actively managed with annual turnover of: 33.00 vs. VSGAX (19.00). JGSVX has a lower initial minimum investment than VSGAX: JGSVX (0) vs VSGAX (3000). VSGAX annual gain was more profitable for investors over the last year : 35.72 vs. JGSVX (33.49). VSGAX return over 5 years is better than : 53.72 vs. JGSVX (13.15).
JGSVXVSGAXJGSVX / VSGAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years13 years-
Gain YTD18.75321.27288%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.75B35.8B10%
Annual Yield % from dividends0.000.66-
Returns for 1 year33.4935.7294%
Returns for 3 years-21.911.64-1,332%
Returns for 5 years13.1553.7224%
Returns for 10 yearsN/A137.60-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
Z82.154.27
+5.48%
Zillow Group
CVBF23.190.62
+2.75%
CVB Financial Corp
BRY4.260.07
+1.67%
Berry Corp
EVOK4.50-0.06
-1.32%
Evoke Pharma, Inc.
CXDO5.03-0.14
-2.71%
Crexendo